OpenVSafe by OpenVAERS
Search V-safe

HB5-29484-16723

3 vaccinations 4 coded responses 38 check-ins 4 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
303 / GA
Registered
2020-12-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-20
    Registered in v-safe
  2. 2020-12-20
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-20
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2020-12-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2020-12-27
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-10
    Dose 2 — Pfizer-BioNTech
  13. 2021-01-10
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-01-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Chills, Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  15. 2021-01-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-01-17
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-01-24
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-01-31
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-07
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-14
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-02-21
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-11
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-07-11
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-09-29
    Dose 3 — Pfizer-BioNTech
    Co-administered: Flu
  28. 2021-09-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activities
    Adult check-in
  29. 2021-10-01
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy, Palpitations — Feeling: Fair · Site: Pain
    Free text: Palpitations and lymphadenopathy in affected underarm
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-10-02
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Lymphadenopathy in axilla
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-10-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  32. 2021-10-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  33. 2021-10-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-10-06
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-10-15
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-10-20
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-10-27
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-11-03
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-11-10
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-12-29
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-03-30
    Survey response — 6 months, dose 3
    MedDRA: Abortion spontaneous, Aphonia, Cough, Oropharyngeal pain, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Had 1-2 weeks of cough, sore throat and complete loss of voice. Tested negative for COVID. Also experienced a miscarriage.
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-03-30
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  43. 2022-04-05
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  44. 2022-10-01
    Survey response — 12 months, dose 3
    MedDRA: Abortion spontaneous, Abortion threatened, COVID-19 — Feeling: Good · Be unable to work or attend school
    Free text: COVID Miscarriage Threatened miscarriage
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-20Pfizer-BioNTech
22021-01-10Pfizer-BioNTech
32021-09-29Pfizer-BioNTech Flu

Call center

ReportedOutcomeVAERS-related outcome
2022-03-30 Successful
2022-04-05
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Free text

Release 9 — days 1–6 daily, dose 3

2021-10-01

Systemic reaction (other): Palpitations and lymphadenopathy in affected underarm

2021-10-02

Systemic reaction (other): Lymphadenopathy in axilla

Release 11 — 6 months, dose 3

2022-03-30

Symptoms: Had 1-2 weeks of cough, sore throat and complete loss of voice. Tested negative for COVID. Also experienced a miscarriage.

Release 12 — 12 months, dose 3

2022-10-01

Symptoms: COVID Miscarriage Threatened miscarriage

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbortion spontaneous · · ✓
SDAbortion threatened · · ✓
SDAphonia · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDOropharyngeal pain · · ✓
SDSARS-CoV-2 test negative · · ✓
SROLymphadenopathy · · ✓
SROPalpitations · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release